Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Dobbins

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Physiology|May 18, 1999
Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivoL S Szczepaniak, E E Babcock, F Schick, et al.
Diabetes, Obesity & Metabolism|May 25, 2013
GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitusR L Dobbins, S P Shearn, R L Byerly, et al.
Diabetes, Obesity & Metabolism|February 4, 2009
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjectsM A Bush, J E Matthews, E H De Boever, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Physiology|May 18, 1999
Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivoL S Szczepaniak, E E Babcock, F Schick, et al.
Diabetes, Obesity & Metabolism|May 25, 2013
GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitusR L Dobbins, S P Shearn, R L Byerly, et al.
Diabetes, Obesity & Metabolism|February 4, 2009
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjectsM A Bush, J E Matthews, E H De Boever, et al.
Pageof 2